All In Biotech

Drug Trial Radar · NCT07742735

A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF)

A Parallel-group Treatment, Phase 3, Double-blind, Randomized, 2-arm Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF)

Last checked: Nov 19, 2026Latest source record: Aug 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 124 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

124

Planned (sponsor's estimate)

Start

Aug 2026

Primary completion

Oct 2028

Study completion Oct 2029

Sponsor

Lead sponsor
VectivBio AGIndustry
Sponsor type
Industry
Collaborators
PSI CRO
First posted
Aug 3, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This Phase 3 placebo-controlled study is planned to further investigate the efficacy, safety, and tolerability of apraglutide in the overall SBS-IF (short bowel syndrome associated with intestinal failure) population during 24 weeks of study treatment. It is expected that approximately 124 participants will be randomized worldwide to either apraglutide or placebo in a 1:1 ratio in this trial.

Conditions

  • Short Bowel Syndrome (SBS)
  • SBS Associated With Intestinal Failure (SBS-IF)

Interventions

  • ApraglutideDrug

    Apraglutide is a synthetic peptide analogue of glucagon-like peptide-2 (GLP-2), which acts as a full agonist at the GLP-2 receptor with in vitro potency and selectivity comparable with native GLP-2. Participants will be administered or will self-administer a weekly SC injection of apraglutide.

  • PlaceboDrug

    Participants will be administered or will self-administer a weekly single SC injection of placebo in the matching injection volumes.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Relative change from baseline in actual weekly PS volume at Week 24.Time frame: At Week 24

Locations

94 sites in 22 countries. Site status is shown where the registry gives one.

  • Ronald Reagan UCLA Medical Center, Center for the Health Sciences

    Los Angeles, California · Not yet recruiting

  • Denver Health Medical Center

    Denver, Colorado · Not yet recruiting

  • MedStar Georgetown University Hospital

    Washington D.C., District of Columbia · Not yet recruiting

  • University of Florida Health (UF Health)

    Gainesville, Florida · Not yet recruiting

  • GI Pros

    Naples, Florida · Recruiting

  • Cleveland Clinic Florida

    Weston, Florida · Not yet recruiting

  • Loyola University Medical Center

    Maywood, Illinois · Not yet recruiting

  • UofL Physicians - Colon & Rectal Surgery

    Louisville, Kentucky · Not yet recruiting

  • Henry Ford Medical Center - Columbus

    Novi, Michigan · Not yet recruiting

  • Albany Medical Center

    Albany, New York · Not yet recruiting

  • Mount Sinai Medical Center, RMTI - Intestinal Transplantation & Rehabilitation

    New York, New York · Not yet recruiting

  • Duke University Medical Center

    Durham, North Carolina · Not yet recruiting

  • Gastro Health - Clifton

    Cincinnati, Ohio · Not yet recruiting

  • Cleveland Clinic - Cleveland

    Cleveland, Ohio · Not yet recruiting

  • OSU Wexner Medical Center

    Columbus, Ohio · Not yet recruiting

  • Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvania · Not yet recruiting

  • Vanderbilt University Medical Center

    Nashville, Tennessee · Not yet recruiting

  • Buenos Aires Italian Hospital

    Buenos Aires, Argentina · Not yet recruiting

  • Allende Sanatorium

    Córdoba, Argentina · Not yet recruiting

  • San Martin General La Plata Acute General Regional Hospital

    La Plata, Argentina · Not yet recruiting

  • CDC Medical Center

    Luján, Argentina · Not yet recruiting

  • St Vincent's Hospital (Melbourne) Ltd

    Fitzroy, Australia · Not yet recruiting

  • Austin Hospital

    Heidelberg, Australia · Not yet recruiting

  • Royal Brisbane and Women's Hospital, Gastroenterology and Hepatology

    Herston, Australia · Not yet recruiting

  • Fiona Stanley Hospital, Harry Perkins Medical Research Institute

    Perth, Australia · Not yet recruiting

  • University Hospital Graz

    Graz, Austria · Not yet recruiting

  • Order Hospital Linz Ltd. - Hospital of Sisters of Mercy, Department of Surgery

    Linz, Upper Austria, Austria · Not yet recruiting

  • University Hospital Antwerp (UZA), Department of Gastroenterology and Hepatology

    Edegem, Belgium · Not yet recruiting

  • University Hospitals Leuven, Campus Gasthuisberg, Department of Gastroenterology

    Leuven, Belgium · Not yet recruiting

  • Hospital Sao Marcos

    Teresina, Piauí, Brazil · Not yet recruiting

  • Caxias Do Sul University / Clinical Research For Multicenter Studies Institute

    Caxias do Sul, Rio Grande do Sul, Brazil · Not yet recruiting

  • Porto Alegre Clinical Hospital (HCPA)

    Porto Alegre, Rio Grande do Sul, Brazil · Not yet recruiting

  • Pontifical University Of Rio Grande Do Sul (PUCRS) - St. Luke Hospital

    Porto Alegre, Rio Grande do Sul, Brazil · Not yet recruiting

  • Regional Medical School Foundation (CIP HB/FAMERP)

    São José do Rio Preto, São Paulo, Brazil · Not yet recruiting

  • QualiVida Higienopolis - Hapvida NotreDame

    São Paulo, São Paulo, Brazil · Not yet recruiting

  • University of São Paulo Faculty of Medicine Clinics Hospital

    São Paulo, São Paulo, Brazil · Not yet recruiting

  • Pacific Gastroenterology Associates

    Vancouver, British Columbia, Canada · Not yet recruiting

  • CHUM - University of Montreal Hospital Centre

    Montreal, Quebec, Canada · Not yet recruiting

  • University Hospital Brno, Clinic of Internal Medicine - Gastroenterology

    Brno, Czechia · Not yet recruiting

  • University Hospital Hradec Kralove, 3rd Internal Clinic of Geronto-Metabolic

    Hradec Králové, Czechia · Not yet recruiting

Showing 40 of 94 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.